Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,008 public trials 572 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma

NCT01605032

Conditions
Blood Protein Disorders, Cardiovascular Diseases, DS Stage I Plasma Cell Myeloma, +16 more
Locations
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • NYU Cancer Institute New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Albert Einstein College of Medicine The Bronx, New York, United States
View Trial Details
Completed

Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Clinical Activity of GSK2857916

NCT02064387

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Chapel Hill, North Carolina, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia

NCT00004889

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • Walter Reed Army Medical Center Washington D.C., District of Columbia, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View Trial Details

Related conditions